XML 13 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2025
Oct. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 33,704 $ 50,611
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 23,609 15,910
Stock-based compensation expense 174,960 161,857
Amortization of deferred commissions 39,895 39,377
Deferred income taxes 19,637 4,866
Induced conversion expense 0 10,139
Other (5,063) (7,362)
Changes in operating assets and liabilities:    
Accounts receivable, net 88,111 90,764
Deferred commissions (34,813) (30,860)
Operating lease right-of-use assets, net 16,101 18,171
Other assets (4,211) (26)
Accounts payable, accrued expenses and other liabilities (22,644) (10,519)
Operating lease liabilities (19,865) (21,658)
Deferred revenue (63,354) (91,186)
Net cash provided by operating activities 246,067 230,084
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of short-term investments (82,260) (90,676)
Maturities of short-term investments 86,400 97,396
Sales of short-term investments 0 3,567
Purchases of property and equipment (4,152) (1,945)
Proceeds from sales of property and equipment 252 8,395
Capitalized software costs (26,453) (19,031)
Other 0 (3,525)
Net cash used in investing activities (26,213) (5,819)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible notes, net of issuance costs 0 448,953
Partial repurchase of convertible notes 0 (191,713)
Purchase of capped calls related to convertible notes 0 (52,486)
Settlement of capped calls related to convertible notes 0 30,313
Principal payments on borrowings 0 (30,000)
Repurchases of common stock (166,436) (168,651)
Payments of dividends to preferred stockholders (11,250) (11,250)
Proceeds from exercise of stock options 1,455 16,170
Proceeds from issuances of common stock under employee stock purchase plan 27,168 25,910
Employee payroll taxes paid for net settlement of stock awards (67,088) (58,089)
Other (735) (4,163)
Net cash (used in) provided by financing activities (216,886) 4,994
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 5,740 (3,470)
Net increase in cash, cash equivalents, and restricted cash 8,708 225,789
Cash, cash equivalents, and restricted cash, beginning of period [1] 626,110 384,257
Cash, cash equivalents, and restricted cash, end of period [1] $ 634,818 $ 610,046
[1] Restricted cash is included in other current assets in the condensed consolidated balance sheets for the periods presented.